Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy U Lin

Showing results (191-200 of 330) with videos related to

Pageof 33
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional studyInes Vaz-Luis, Rebecca A Ottesen, Melissa E Hughes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2022
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline UpdateSharon H Giordano, Maria Alice B Franzoi, Sarah Temin, et al.
JCO Oncology Practice|May 16, 2023
Identifying Patterns and Barriers in OncotypeDX Recurrence Score Testing in Older Patients With Early-Stage, Estrogen Receptor-Positive Breast Cancer: Implications for Guidance and ReimbursementDario Trapani, Qingchun Jin, Caroline C Block, et al.
Breast Cancer Research and Treatment|October 12, 2013
Prospective clinical experience with research biopsies in breast cancer patientsInes Vaz-Luis, Catherine A Zeghibe, Elizabeth S Frank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2018
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline UpdateNaren Ramakrishna, Sarah Temin, Sarat Chandarlapaty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2018
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline UpdateSharon H Giordano, Sarah Temin, Sarat Chandarlapaty, et al.
Neuro-Oncology|April 27, 2017
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based studyDaniel N Cagney, Allison M Martin, Paul J Catalano, et al.
NPJ Breast Cancer|August 8, 2018
Unraveling the clinicopathological features driving the emergence of <i>ESR1</i> mutations in metastatic breast cancerYanan Kuang, Bilal Siddiqui, Jiani Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2024
Integrative Multiomic Profiling of Triple-Negative Breast Cancer for Identifying Suitable TherapiesBojana Jovanović, Sarah E Church, Kara M Gorman, et al.
JAMA Oncology|June 23, 2022
Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast CancerPaolo Tarantino, Qingchun Jin, Nabihah Tayob, et al.
Pageof 33

Showing results (191-200 of 330) with videos related to

Sort By:
Pageof 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional studyInes Vaz-Luis, Rebecca A Ottesen, Melissa E Hughes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2022
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline UpdateSharon H Giordano, Maria Alice B Franzoi, Sarah Temin, et al.
JCO Oncology Practice|May 16, 2023
Identifying Patterns and Barriers in OncotypeDX Recurrence Score Testing in Older Patients With Early-Stage, Estrogen Receptor-Positive Breast Cancer: Implications for Guidance and ReimbursementDario Trapani, Qingchun Jin, Caroline C Block, et al.
Breast Cancer Research and Treatment|October 12, 2013
Prospective clinical experience with research biopsies in breast cancer patientsInes Vaz-Luis, Catherine A Zeghibe, Elizabeth S Frank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2018
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline UpdateNaren Ramakrishna, Sarah Temin, Sarat Chandarlapaty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2018
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline UpdateSharon H Giordano, Sarah Temin, Sarat Chandarlapaty, et al.
Neuro-Oncology|April 27, 2017
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based studyDaniel N Cagney, Allison M Martin, Paul J Catalano, et al.
NPJ Breast Cancer|August 8, 2018
Unraveling the clinicopathological features driving the emergence of <i>ESR1</i> mutations in metastatic breast cancerYanan Kuang, Bilal Siddiqui, Jiani Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2024
Integrative Multiomic Profiling of Triple-Negative Breast Cancer for Identifying Suitable TherapiesBojana Jovanović, Sarah E Church, Kara M Gorman, et al.
JAMA Oncology|June 23, 2022
Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast CancerPaolo Tarantino, Qingchun Jin, Nabihah Tayob, et al.
Pageof 33